PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.49%
Negative revenue growth while IXX.DE stands at 41.09%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-10.59%
Negative gross profit growth while IXX.DE is at 66.52%. Joel Greenblatt would examine cost competitiveness or demand decline.
23.47%
EBIT growth below 50% of IXX.DE's 650.31%. Michael Burry would suspect deeper competitive or cost structure issues.
23.47%
Operating income growth under 50% of IXX.DE's 693.32%. Michael Burry would be concerned about deeper cost or sales issues.
82.80%
Positive net income growth while IXX.DE is negative. John Neff might see a big relative performance advantage.
69.29%
Positive EPS growth while IXX.DE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
69.29%
Positive diluted EPS growth while IXX.DE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
9.26%
Slight or no buybacks while IXX.DE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
10.00%
Slight or no buyback while IXX.DE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-102.96%
Firm’s AR is declining while IXX.DE shows 12.92%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
7.04%
We show growth while IXX.DE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-2.26%
Negative asset growth while IXX.DE invests at 7.41%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
7.85%
1.25-1.5x IXX.DE's 5.46%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-13.44%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-6.17%
We cut SG&A while IXX.DE invests at 0.17%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.